down arrow

Zhongzhi Pharmaceutical Holdings Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG989611085
  • HKG: 3737
HKD
0.74
0.01 (0.68%)

Sep 23

HKG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd.
Zhongzhi Pharmaceutical Holdings Ltd.
China Shineway Pharmaceutical Group Ltd.
Shandong Xinhua Pharmaceutical Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
CK Life Sciences International (Holdings), Inc.
HBM Holdings Ltd.
Wai Yuen Tong Medicine Holdings Ltd.
PuraPharm Corp. Ltd.
Hin Sang Group (International) Holding Co. Ltd.
China Health Group, Inc.

Why is Zhongzhi Pharmaceutical Holdings Ltd. ?

1
Weak Long Term Fundamental Strength with a -19.81% CAGR growth in Operating Profits over the last 5 years
  • The company is Net-Debt Free
2
Flat results in Jun 26
  • OPERATING CASH FLOW(Y) Lowest at HKD 358.62 MM
  • RAW MATERIAL COST(Y) Grown by 8.54% (YoY)
  • NET SALES(Q) Lowest at HKD 900.54 MM
3
With ROE of 1.40%, it has a Very Attractive valuation with a 0.50 Price to Book Value
  • Over the past year, while the stock has generated a return of 7.25%, its profits have fallen by -83.7%
  • At the current price, the company has a high dividend yield of 0
4
Market Beating Performance
  • Even though the market (Hang Seng Hong Kong) has generated negative returns of -4.77% in the last 1 year, the stock has been able to generate 7.25% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Zhongzhi Pharmaceutical Holdings Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhongzhi Pharmaceutical Holdings Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Zhongzhi Pharmaceutical Holdings Ltd.
9.56%
-0.43
66.36%
Hang Seng Hong Kong
-5.07%
-0.26
18.70%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.86%
EBIT Growth (5y)
-19.81%
EBIT to Interest (avg)
19.56
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
1.57
Tax Ratio
43.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.24%
ROE (avg)
12.09%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
35
Industry P/E
Price to Book Value
0.50
EV to EBIT
10.69
EV to EBITDA
3.56
EV to Capital Employed
0.49
EV to Sales
0.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.60%
ROE (Latest)
1.40%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
PRE-TAX PROFIT(Q)

At HKD 15.43 MM has Grown at 2,293.9%

DEBT-EQUITY RATIO (HY)

Lowest at -0.6 %

CASH AND EQV(HY)

Highest at HKD 243.88 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 2.96 times

-4What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at HKD 358.62 MM

RAW MATERIAL COST(Y)

Grown by 8.54% (YoY

NET SALES(Q)

Lowest at HKD 900.54 MM

Here's what is working for Zhongzhi Pharmaceutical Holdings Ltd.

Pre-Tax Profit
At HKD 15.43 MM has Grown at 2,293.9%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (HKD MM)

Debt-Equity Ratio
Lowest at -0.6 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Cash and Eqv
Highest at HKD 243.88 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio
Highest at 2.96 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Zhongzhi Pharmaceutical Holdings Ltd.

Operating Cash Flow
Lowest at HKD 358.62 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Net Sales
Lowest at HKD 900.54 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (HKD MM)

Raw Material Cost
Grown by 8.54% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading